F16.121 Hallucinogen abuse with intoxication with delirium

Name of the Condition

• Hallucinogen Abuse with Intoxication with Delirium
• Medical Term: ICD-10-CM F16.121

Summary

Hallucinogen abuse with intoxication with delirium describes a pattern of problematic hallucinogen use that leads to clinically significant impairment or distress, accompanied by acute intoxication and delirium. This condition involves the use of substances that alter perception, mood, and consciousness, resulting in immediate adverse effects during or shortly after use, including a state of confusion and disorientation.

Causes

Hallucinogen abuse with intoxication with delirium typically arises from the recreational use of substances such as LSD, psilocybin mushrooms, mescaline, or PCP. These drugs are often sought for their mind-altering effects, which can lead to repeated use despite negative consequences, including intoxication and delirium.

Risk Factors

• Peer pressure or social influences encouraging drug use
• Curiosity or desire for altered states of consciousness
• Pre-existing mental health disorders
• Genetic predisposition to substance use disorders
• Easy access to hallucinogenic substances

Symptoms

• Visual or auditory hallucinations
• Altered perception of reality or time
• Euphoria or dysphoria
• Impaired coordination or speech
• Anxiety, paranoia, or panic reactions
• Confusion or disorientation (delirium)
• Fluctuating level of consciousness

Diagnosis

Diagnosis is primarily clinical, based on a patient's history of substance use and reported symptoms. Mental health assessments may be used to evaluate the impact of use, and toxicology screens can confirm the presence of hallucinogens. Delirium is identified through observation of acute confusion, disorientation, and fluctuating mental status.

Treatment Options

Treatment focuses on managing acute symptoms, ensuring safety, and addressing underlying substance use. This may include supportive care, monitoring for complications, and referral to substance use disorder programs. Pharmacological interventions may be used to manage severe agitation or psychosis, while behavioral therapies support long-term recovery.

Prognosis and Follow-Up

Prognosis depends on the severity of intoxication and delirium, as well as the patient's response to treatment. Follow-up care is essential to address ongoing substance use and prevent recurrence. Regular monitoring and support can improve outcomes, though relapse is possible without sustained intervention.

Complications

• Severe confusion or disorientation
• Risk of injury due to impaired judgment
• Prolonged cognitive impairment
• Worsening of pre-existing mental health conditions
• Potential for substance use disorder progression

Lifestyle & Prevention

• Avoiding hallucinogenic substances
• Seeking healthy coping mechanisms for stress
• Building a support network
• Engaging in education about substance risks
• Addressing underlying mental health concerns

When to Seek Professional Help

Seek immediate medical attention if experiencing severe confusion, hallucinations, or impaired coordination after using hallucinogens. Persistent symptoms or concerns about substance use warrant evaluation by a healthcare provider.

Tips for Medical Coders

Document the presence of delirium as a key feature of this condition. Ensure clinical notes specify acute intoxication with hallucinogens and the associated delirium to support accurate coding. Verify that the diagnosis aligns with the clinical presentation and substance use history.